SEMA7A as a Novel Prognostic Biomarker and Its Correlation with Immune Infiltrates in Breast Cancer.
Shiyu ZhangFanting KongLei ZhengXiaowei LiLining JiaLixian YangPublished in: International journal of general medicine (2024)
SEMA7A has the potential to function as a prognostic indicator for BC, and its correlation with immune infiltration in BC is significant.
Keyphrases